Turn Therapeutics Inc. SEC filings TTRX
Turn Therapeutics Inc. has 122 filings in SEC EDGAR's recent list, going back to May 22, 2024. Its latest annual report, Form ARS, was filed on Oct 19, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 7, 2026 (regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| D | Filing | Aug 26, 2026 | — |
| C-TR | Filing | May 13, 2026 | — |
| EFFECT | Filing | Apr 2, 2026 | — |
| EFFECT | Filing | Apr 2, 2026 | — |
| CERT | Filing | Oct 7, 2025 | — |
| 8-A12B/A | Filing | Oct 7, 2025 | — |
| EFFECT | Filing | Sep 30, 2025 | — |
| 8-A12B | Filing | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| CORRESP | Letter to the SEC | Sep 24, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 23, 2025 | — |
| 1-SA | Filing | Sep 22, 2025 | Jun 30, 2025 |
| CORRESP | Letter to the SEC | Sep 16, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 11, 2025 | — |
| DRS | Filing | Sep 3, 2025 | — |
| CORRESP | Letter to the SEC | Aug 29, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 14, 2025 | — |
| DRSLTR | Filing | Jul 30, 2025 | — |
| DRS/A | Filing | Jul 30, 2025 | — |
| 1-K | Filing | Jun 27, 2025 | Dec 31, 2024 |
| DRS | Filing | Jun 20, 2025 | — |
| 253G2 | Filing | Jun 13, 2025 | — |
| C-AR | Filing | Apr 29, 2025 | Dec 31, 2024 |
| 253G2 | Filing | Apr 22, 2025 | — |
| 253G2 | Filing | Apr 2, 2025 | — |
| QUALIF | Filing | Mar 31, 2025 | — |
| CORRESP | Letter to the SEC | Mar 27, 2025 | — |
| 1-A/A | Filing | Mar 27, 2025 | — |
| 1-A/A | Filing | Mar 26, 2025 | — |
| CORRESP | Letter to the SEC | Mar 25, 2025 | — |
| 1-A/A | Filing | Mar 25, 2025 | — |
| C-U | Filing | Mar 25, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 24, 2025 | — |
| CORRESP | Letter to the SEC | Mar 18, 2025 | — |
| 1-A/A | Filing | Mar 18, 2025 | — |
| UPLOAD | Letter from the SEC | Mar 17, 2025 | — |
| CORRESP | Letter to the SEC | Mar 6, 2025 | — |
| 1-A/A | Filing | Mar 6, 2025 | — |
| UPLOAD | Letter from the SEC | Feb 27, 2025 | — |
| 1-A | Filing | Jan 31, 2025 | — |
| C/A | Filing | Jan 17, 2025 | — |
| C/A | Filing | Dec 18, 2024 | — |
| C-U | Filing | Nov 12, 2024 | — |
| C | Filing | Oct 22, 2024 | — |
| C/A | Filing | Aug 19, 2024 | — |
| C/A | Filing | Jul 15, 2024 | — |
| C | Filing | May 22, 2024 | — |
Showing 47 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TTRX (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Westlake Village, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 2023016
- Former names
- Global Health Solutions, Inc (until Sep 30, 2025)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.